Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Key to controlling COVID-19 is early intervention

A study published in the journal Royal Society Open Science demonstrates the critical role of timely intervention in New Zealand's success story. The researchers used a stochastic branching process model to simulate the trajectory of COVID-19 transmission and control during New Zealand's 2020 outbreak. They calculated the number of reported cases and deaths and the probability of elimination within a defined time frame.

25 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

What may the future hold in terms of SARS-CoV-2 variants?

Researchers fit data on SARS-CoV-2 variants by exploiting a function that depends on the global number of infected cases since the start of the pandemic.

25 Nov 2021

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

Researchers measured anti-RBD IgG and virus neutralization before and after vaccination with boosters.

25 Nov 2021

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Some of the UK's leading health charities including the British Heart Foundation, Diabetes UK and Cancer Research UK are joining forces with the government and the NHS to encourage vulnerable people to get their COVID-19 vaccines.

25 Nov 2021

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors-;not just the alpha variant of the virus that causes COVID-19-;were to blame.

25 Nov 2021

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

In a study published in The Lancet Infectious Diseases, researchers investigated the effectiveness of the BBV152 vaccine among employees of the All India Institute of Medical Sciences.

25 Nov 2021

Safety and immunogenicity of COVID-19 peptide vaccine

In a study published in Nature, researchers from University Hospital Tübingen have been investigating the results from a Phase I trial for a new vaccine against SARS-CoV-2 variants.

25 Nov 2021

Researchers investigate Moderna COVID-19 vaccine efficacy

Researchers have been investigating the vaccine efficacy of the mRNA-1273 vaccine.

25 Nov 2021

SARS-CoV-2 Delta variant mutation sites

A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.

25 Nov 2021

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Researchers recently published a study assessing the risks of patients with MM to breakthrough infections after completing their vaccination schedule compared to those without any form of cancer.

25 Nov 2021

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

A new study published on the medRxiv* preprint server employed in-silico techniques, combining genomic and epidemiological data, to determine possible Delta-variant transmission events between vaccinated healthcare workers (HCWs) in Indian hospitals.

25 Nov 2021

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

In this perspective, a new study published on the medRxiv* preprint server analyzed the clinical efficacy of two serum antigen tests to identify SARS CoV-2 infection and evaluate the kinetics of serum nucleocapsid (N) antigen in severe and non-severe patients for disease severity prediction.

24 Nov 2021

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Death rates from COVID-19 are especially high in individuals with kidney failure who are on dialysis, making SARS-CoV-2 vaccination in this population a high priority.

24 Nov 2021

Maternal-fetal interface yields intriguing clues to how it battles SARS-CoV-2

Scientists have hypothesized that the number of immune cells and the amount of cytokines produced in response to SARS-CoV-2 infection in pregnant women change in accordance with the timing of maternal infection in pregnancy. This study is available on the bioRxiv* preprint server.

24 Nov 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Key to controlling COVID-19 is early intervention

Using metal nanoparticles to fight SARS-CoV-2

What may the future hold in terms of SARS-CoV-2 variants?

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

Safety and immunogenicity of COVID-19 peptide vaccine

Researchers investigate Moderna COVID-19 vaccine efficacy

SARS-CoV-2 Delta variant mutation sites

Study shows vaccinated multiple myeloma patients at greater risk of breakthrough SARS-CoV-2 infections

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Maternal-fetal interface yields intriguing clues to how it battles SARS-CoV-2

Innovative algorithm predicts COVID-related intensive care unit resource use

Can COVID-19 affect erectile function?

Combination of iota-carrageenan and xylitol as a potential nasal spray for COVID

Acute SARS-CoV-2 infection during pregnancy associated with placental ACE2 shedding

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in